These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22466064)

  • 21. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study.
    Tully AM; Roche HM; Doyle R; Fallon C; Bruce I; Lawlor B; Coakley D; Gibney MJ
    Br J Nutr; 2003 Apr; 89(4):483-9. PubMed ID: 12654166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Recent Update on the Effects of Omega-3 Fatty Acids in Alzheimer's Disease.
    Ajith TA
    Curr Clin Pharmacol; 2018; 13(4):252-260. PubMed ID: 30084334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipidomic alterations in lipoproteins of patients with mild cognitive impairment and Alzheimer's disease by asymmetrical flow field-flow fractionation and nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry.
    Kim SH; Yang JS; Lee JC; Lee JY; Lee JY; Kim E; Moon MH
    J Chromatogr A; 2018 Sep; 1568():91-100. PubMed ID: 30007793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary DHA supplementation causes selective changes in phospholipids from different brain regions in both wild type mice and the Tg2576 mouse model of Alzheimer's disease.
    Bascoul-Colombo C; Guschina IA; Maskrey BH; Good M; O'Donnell VB; Harwood JL
    Biochim Biophys Acta; 2016 Jun; 1861(6):524-37. PubMed ID: 26968097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier?
    Pan Y; Khalil H; Nicolazzo JA
    Curr Clin Pharmacol; 2015; 10(3):222-41. PubMed ID: 26338174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Human Milk and Parenteral Lipid Emulsions on Serum Fatty Acid Profiles in Extremely Preterm Infants.
    Nilsson AK; Löfqvist C; Najm S; Hellgren G; Sävman K; Andersson MX; Smith LEH; Hellström A
    JPEN J Parenter Enteral Nutr; 2019 Jan; 43(1):152-161. PubMed ID: 29679529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study.
    Irving GF; Freund-Levi Y; Eriksdotter-Jönhagen M; Basun H; Brismar K; Hjorth E; Palmblad J; Vessby B; Vedin I; Wahlund LO; Cederholm T
    J Am Geriatr Soc; 2009 Jan; 57(1):11-7. PubMed ID: 19054188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Int J Mol Sci; 2015 Oct; 16(10):24600-13. PubMed ID: 26501267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomics based identification of differential plasma proteins and changes in white matter integrity as markers in early detection of mild cognitive impaired subjects at high risk of Alzheimer's disease.
    Kumar A; Singh S; Verma A; Mishra VN
    Neurosci Lett; 2018 May; 676():71-77. PubMed ID: 29649488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review.
    Canhada S; Castro K; Perry IS; Luft VC
    Nutr Neurosci; 2018 Oct; 21(8):529-538. PubMed ID: 28466678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of an omega-3 fatty acid rich lipid emulsion on fatty acid profiles in critically ill septic patients.
    Hall TC; Bilku DK; Neal CP; Cooke J; Fisk HL; Calder PC; Dennison AR
    Prostaglandins Leukot Essent Fatty Acids; 2016 Sep; 112():1-11. PubMed ID: 27637335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Contribution of omega-3 fatty acids for memory and cognitive function].
    Waitzberg DL; Garla P
    Nutr Hosp; 2014 Sep; 30(3):467-77. PubMed ID: 25238820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer's disease.
    Voigt RM; Raeisi S; Yang J; Leurgans S; Forsyth CB; Buchman AS; Bennett DA; Keshavarzian A
    PLoS One; 2021; 16(3):e0240342. PubMed ID: 33661922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of fish oils containing different amounts of EPA, DHA, and antioxidants on plasma and brain fatty acids and brain nitric oxide synthase activity in rats.
    Engström K; Saldeen AS; Yang B; Mehta JL; Saldeen T
    Ups J Med Sci; 2009; 114(4):206-13. PubMed ID: 19961266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease.
    Rijpma A; Meulenbroek O; van Hees AM; Sijben JW; Vellas B; Shah RC; Bennett DA; Scheltens P; Olde Rikkert MG
    Alzheimers Res Ther; 2015; 7(1):51. PubMed ID: 26213579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men.
    Vidgren HM; Agren JJ; Schwab U; Rissanen T; Hänninen O; Uusitupa MI
    Lipids; 1997 Jul; 32(7):697-705. PubMed ID: 9252957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced blood-brain barrier expression of fatty acid-binding protein 5 is associated with increased vulnerability of APP/PS1 mice to cognitive deficits from low omega-3 fatty acid diets.
    Pan Y; Choy KHC; Marriott PJ; Chai SY; Scanlon MJ; Porter CJH; Short JL; Nicolazzo JA
    J Neurochem; 2018 Jan; 144(1):81-92. PubMed ID: 29105065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between plasma free fatty acids, cognitive function and structural integrity of the brain in middle-aged healthy humans.
    Herrmann M; Simstich S; Fauler G; Hofer E; Fritz-Petrin E; Herrmann W; Schmidt R
    Aging (Albany NY); 2021 Sep; 13(18):22078-22091. PubMed ID: 34554925
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.